Friday, April 19, 2024
4/19/2024
Normal structure and function of the lung is maintained in homeostasis and repaired/regenerated following diverse injuries by regionally defined stem/progenitor cells. Stem cells reside in unique tissue microenvironments, known as the stem cell “niche”, which constitutes stem cell progeny, other niche-support cells including mesenchymal cells (MCs), and the surrounding extracellular matrix (ECM). The stem cell niche provides instructive cues for stem cell self-renewal and differentiation. Fibrotic lungs undergo substantial changes in the tissue biomechanical properties, manifested by stiffening of the ECM. Cells residing in the stem cell niche sense and respond to alterations in the stiffness of the microenvironment, highlighting matrix stiffness as an important mechanical component of the stem cell niche. In preliminary studies, we have characterized the stiffness of alveolar type 2 epithelial stem cell (AT2) niche associated with Pdgfra+ lung MCs. Alveolar organoid culture in newly developed, stiffness-tunable 3D hydrogels demonstrated that matrix stiffness constitutes an AT2 niche. We recently identified that a6-integrin is a mechanosensitive integrin subunit; stiff matrix-induced a6 expression, primarily an a6 isoform with a shorter cytoplasmic domain (a6S), mediates lung fibroblast invasion into the basement membrane. New preliminary data now show that in addition to a6 expression, matrix stiffness regulates alternative splicing of a6 pre-mRNA in Pdgfra+ lung MCs, resulting in differential expression of a distinct a6 isoform with a longer cytoplasmic domain (a6L) under soft /homeostatic matrix conditions and a switch from a6L to a6S predominance under stiff/fibrotic matrix conditions. We found that a6L expression promotes lipogenic differentiation of lung MCs and confers the AT2- niche function, facilitating reinstatement of lung homeostasis. In contrast, a6S expression impairs the AT2- niche function and promotes fibrogenic/invasive differentiation of lung MCs, contributing to lung fibrosis. In this proposal, we hypothesize that matrix stiffness-dependent alternative splicing of a6-integrin regulates the repair of injured lungs by controlling alveolotrophic vs. fibrogenic differentiation of lung mesenchymal cells. Specific aims in the proposed study are: (1) determination of the mechanisms by which matrix stiffness regulates alternative splicing of a6-integrin; (2) determination of the mechanisms by which distinct a6-integrin cytoplasmic variants mediate alveolotrophic vs. fibrogenic differentiation of lung mesenchymal cells; and (3) testing the potential of targeting matrix stiffness-dependent alternative splicing of a6-integrin for the reversal of sustained pulmonary fibrosis in mice. Understanding the mechanisms by which lung epithelial stem cells interact with their niches in normal vs. pathological repair of the injured lung will provide novel therapeutic approaches to prevent, treat, and potentially reverse pulmonary fibrosis.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
